Warner Chilcott plc (WCRX) Stock Quote

Stock Web

Detailed Quote for Warner Chilcott plc (WCRX)

close 52 Week Information

52 Week High

August 24,2010

Close: 30.57

52 Week Low

September 02,2009

Close: 19.02

Today

5d

1m

3m

1y

more

Last Price
29.01

Change $
0.11

Change %
0.38%

Tick

Bid
29.01

Bid Size
600

Ask
29.03

Ask Size
200

Open
28.92

High
29.20

Low
28.86

Prev Close
28.90

Last Trade
10:36

Volume
164.08 k

52 Wk Hi
30.57

52 Wk Low
19.02

Market Cap
7.32 b

Ex-Div Date
9/9/10

Div Rate
N/A

Yield
N/A

Shares
252,233,982

EPS (TTM)
2.04

PE Ratio
14.20

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Warner Chilcott plc (WCRX)

Sector News | Topic News

News for WCRX

Tue, Aug 24, 2010

9:01 AM

Warner Chilcott Announces Receipt of FDA Response to Citizen Petition - PR Newswire

Fri, Aug 20, 2010

4:07 PM

Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance - PR Newswire

Thu, Aug 12, 2010

5:37 PM

Warner Chilcott Announces Pricing of $750 Million of Senior Notes in Connection with Proposed Leveraged Recapitalization - PR Newswire

7:30 AM

Warner Chilcott Announces $750 Million Senior Notes Offering in Connection with Proposed Leveraged Recapitalization - PR Newswire

Fri, Jul 30, 2010

8:30 AM

Warner Chilcott Announces Proposed Leveraged Recapitalization Including Special Cash Dividend to Shareholders and Updates Full-Year 2010 Financial Guidance - PR Newswire

Wed, Jul 28, 2010

9:00 AM

Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results - PR Newswire

Fri, Jul 16, 2010

8:54 AM

Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product - PR Newswire

Mon, Jun 28, 2010

4:15 PM

Warner Chilcott Announces Receipt of Paragraph IV Certification Notice - PR Newswire

Mon, Jun 21, 2010

8:45 AM

Warner Chilcott to Present at the Wells Fargo Securities Healthcare Conference - PR Newswire

Mon, May 10, 2010

10:00 AM

Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference - PR Newswire

Fri, May 07, 2010

7:02 AM

Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2010 - PR Newswire

Thu, Apr 29, 2010

4:15 PM

Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results - PR Newswire

Mon, Apr 05, 2010

7:00 AM

Warner Chilcott Announces Amendment to Actonel Collaboration Agreement with sanofi-aventis - PR Newswire

Mon, Dec 15, 2008

7:00 AM

Warner Chilcott to Join the Nasdaq-100 Index(R) - Globe Newswire

Fri, Dec 12, 2008

8:05 PM

NASDAQ Announces the Annual Re-Ranking of the NASDAQ-100 Index - Globe Newswire

Mon, Sep 15, 2008

7:00 AM

Semi-annual Changes to the NASDAQ Q-50 Index - Globe Newswire

Mon, Jun 23, 2008

8:31 AM

Warner Chilcott Announces Approval of DORYX Delayed-Release 150 mg Tablets - Globe Newswire

Fri, Jun 06, 2008

10:18 AM

Warner Chilcott to Present At the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference - Globe Newswire

Fri, May 11, 2007

8:02 PM

Semi-Annual Changes to the NASDAQ Biotechnology Index - Globe Newswire

Mon, Dec 18, 2006

5:38 PM

Lead Plaintiff Deadline Approaching for Investors of Warner Chilcott Limited -- WCRX - Globe Newswire

More News for WCRX >>

Tags for Warner Chilcott plc

Research stocks or mutual funds related to Warner Chilcott plc by keywords or tags. Find companies that have a similar focus to WCRX. The keywords below have been associated to WCRX by either user submission or electronic means.

pharmaceutical gmp biotech research pharmaceutical branding pharmaceutical industry strategy pharmaceutical market generic pharmaceutical pharmaceutical investment pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing pharma manufacturing pharma license generic products pharmaceutical cro pharma companies medical marketing active pharmaceutical ingredients pharmaceutical promotion pharmaceutical sales pharma pharmaceutical distributors mckesson products biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports biotech pharmaceutical pr Drugs massengill products pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article contract pharmaceutical pharmaceutical consulting otc products pharmaceutical industry biotech contract pharmaceutical test pharmaceutical studies pharmaceutical strategy pharmaceutical advances pharmaceutical specialty pharmaceutical jobs pharmaceutical out licensing pharmaceutical co promotion

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.